Cramer says CELG even cheaper than PFE, LLY, BMY--says buy even after today's run
Cramer says the "Four Horseman of Pharma" incl Celgene are back ready to go higher..Celgene -$15 EPS in 2015…yet when you look at the out yrs – CELG is even cheaper than PFE, LLY & BMY...Buy even now...will be anointed as go to names for rest of 2013...
AMAZING MAD MONEY SEGMENT - tape it and watch 15 minutes after the start of the show
Cramer: "Celgene just got a European panel approval for the use of a drug called Abraxane in fighting Pancreatic Cancer….there had been plenty of skeptics about Abraxane but now those skeptics have been proven wrong…that along with some negative chatter about Amgen’s Kyprolis including some rumblings about toxicity problems have put some pep into Celgene’s step which had been stalled in the 150s for quite a bit….now Celgene’s breaking out to all time highs… …this stock remains cheaper than all the biotechs I follow – why because Celgene I believe can earn $15 (a share) in 2015…yet when you look at the out yrs – this company is even cheaper then Pfizer, Lilly…and are you ready skeedaddy………Bristol Myyyyyeeeeeersss" (Cramer famous “Myers”)….
Cramer closing segment "The four horseman of the Big Pharma apocalypse have been wandering in the wilderness of late - that stay seeems to be over - I would buy all four of these - BIIB, CELG, GILD and REGN - even after these runs - as these stocks are going to be anointed as go to names for THE REST OF 2013"
They have this video link up but its not playing yet - hopefully it works later tonight...
The four horseman of pharma
Friday, 22 Nov 2013 | 6:15 PM ET
Mad Money host Jim Cramer shares why it's not too late to add biotech names Gilead, Celgene, Biogen Idec and Regerneron to your positions.